Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma

Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma

BackgroundHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide and has a poor prognosis. Thus, there is a need for an effective biomarker to improve and predict the prognosis of HCC.MethodsRNA sequencing data, simple nucleotide variation data, and clinical d...

Full description

Bibliographic Details
Main Authors:	Zebing Song, Xiaodong Song, Hang Li, Zongbing Cheng, Zengyi Mo, Xuewei Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Immunology
Subjects:	hepatocellular carcinoma TMB mutant gene DNAH5 immunotherapy target
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1236995/full

Similar Items

Novel Loss-of-Function Mutations in DNAH1 Displayed Different Phenotypic Spectrum in Humans and Mice
by: Ranjha Khan, et al.
Published: (2021-11-01)

Novel variants in DNAH9 lead to nonsyndromic severe asthenozoospermia
by: Dongdong Tang, et al.
Published: (2021-02-01)

Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
by: Chunchao Zhu, et al.
Published: (2019-04-01)

A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia
by: Fei Huang, et al.
Published: (2023-06-01)

mRNA expression profile of DNAH1 gene in testis tissue of Raini Cashmere goat
by: Mohammadreza Mohammadabadi, et al.
Published: (2022-09-01)

Novel variants in DNAH6 cause male infertility associated with multiple morphological abnormalities of the sperm flagella (MMAF) and ICSI outcomes
by: Zhong-Mei Shao, et al.
Published: (2024-01-01)

Novel compound heterozygous mutations in DNAH1 cause primary infertility in Han Chinese males with multiple morphological abnormalities of the sperm flagella
by: Meng Wang, et al.
Published: (2023-01-01)

Multiomics Analysis of a <i>DNAH5</i>-Mutated PCD Organoid Model Revealed the Key Role of the TGF-β/BMP and Notch Pathways in Epithelial Differentiation and the Immune Response in <i>DNAH5</i>-Mutated Patients
by: Wenhao Yang, et al.
Published: (2022-12-01)

Genetic Variations and mRNA Expression of Goat <i>DNAH1</i> and Their Associations with Litter Size
by: Zhen Wang, et al.
Published: (2022-04-01)

Novel axonemal protein ZMYND12 interacts with TTC29 and DNAH1, and is required for male fertility and flagellum function
by: Denis Dacheux, et al.
Published: (2023-11-01)

A Novel Compound Heterozygous Mutation in the DNAH11 Gene Found in Neonatal Twins With Primary Ciliary Dyskinesis
by: Shumei Dong, et al.
Published: (2022-02-01)

ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma
by: Tao Xing, et al.
Published: (2024-01-01)

Identification of DNAH17 Variants in Han-Chinese Patients With Left–Right Asymmetry Disorders
by: Xuehui Yu, et al.
Published: (2022-05-01)

A novel homozygous frameshift variant in DNAH8 causes multiple morphological abnormalities of the sperm flagella in a consanguineous Pakistani family
by: Sobia Dil, et al.
Published: (2023-01-01)

Identification of novel compound heterozygous variants in the DNAH1 gene of a Chinese family with left-right asymmetry disorder
by: Lamei Yuan, et al.
Published: (2023-06-01)

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
by: Chiao-Fang Teng, et al.
Published: (2020-08-01)

Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers
by: Timothy V. Pham, et al.
Published: (2021-10-01)

Fetal Congenital Heart Disease Caused by Compound Heterozygous Mutations in the DNAH9 Gene: A Case Report
by: Tao Zhang, et al.
Published: (2022-01-01)

Identification of Pathogenic Mutations and Investigation of the NOTCH Pathway Activation in Kartagener Syndrome
by: Yongjian Yue, et al.
Published: (2019-08-01)

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
by: Bufu Tang, et al.
Published: (2020-10-01)

Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy
by: Ya-Ru Miao, et al.
Published: (2022-09-01)

ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
by: Yao Chen, et al.
Published: (2020-09-01)

Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma
by: Alessandro Rizzo, et al.
Published: (2021-01-01)

DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden
by: Hao Huang, et al.
Published: (2023-01-01)

The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
by: Yaxiong Zhang, et al.
Published: (2019-04-01)

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
by: Qijiong Li, et al.
Published: (2017-08-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
by: Zhixun Bai, et al.
Published: (2022-12-01)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
by: Jun Liu, et al.
Published: (2022-02-01)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
by: Juan Lu, et al.
Published: (2022-08-01)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
by: Tingbo Ye, et al.
Published: (2022-05-01)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
by: Yixian He, et al.
Published: (2023-04-01)

Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type
by: Lorraine Dalens, et al.
Published: (2023-04-01)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
by: Shengliang Zhang, et al.
Published: (2022-04-01)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
by: Danilo Rocco, et al.
Published: (2023-09-01)

Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma
by: Liqin Xu, et al.
Published: (2022-08-01)

Recent advances in systemic therapy for hepatocellular carcinoma
by: Huajun Zhang, et al.
Published: (2022-01-01)

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
by: Reinhard Dummer, et al.
Published: (2023-08-01)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
by: Xiaoting Luo, et al.
Published: (2024-02-01)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01)